Searches both Title and Fulltext content
Takes you to the requested Key Event
Clear Search Terms Clears search terms and filters

Showing 26 to 50 of 1937 Key Events

Clear Table Filters
ID Title Event Component Count Biological Organization Created At Last Updated AOPs
309 Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development
3 Cellular Nov 29, 2016 May 27, 2026
173 N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number
3 Organ Nov 29, 2016 Sep 16, 2017 31: Oxidation of iron in hemoglobin leading to hematotoxicity
39 Increased Cholinergic Signaling
3 Organ Nov 29, 2016 Dec 20, 2019
2308 Increased, stimulation of brain serotonin 5-HT1a, 5-HT2c receptors
3 Organ Jan 14, 2025 Feb 13, 2025 568: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) leads to Inhibition, Feeding
2159 Influenza A virus (IAV) cell entry
3 Cellular Aug 11, 2023 Oct 3, 2023 506: Binding of Influenza A Virus (IAV) to Sialic Acid Glycan Receptor leads to viral infection proliferation
1235 Non-neuronal production of IL-8/CXCL1, Epithelial irritation
3 Tissue Nov 29, 2016 Dec 3, 2016 None
1238 Activation of oxidative stress pathway
3 Molecular Nov 29, 2016 Jun 19, 2017 594: Micro plastic effect on reproduction
1243 Altered, Ca2+-calmodulin activated signal transduction
3 Cellular Nov 29, 2016 Jun 7, 2018
1132 Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal
3 Cellular Nov 29, 2016 Dec 3, 2016 187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
1134 Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone
3 Molecular Nov 29, 2016 Dec 3, 2016 187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
1495 Substance interaction with the lung resident cell membrane components
3 Molecular Jan 2, 2018 Jun 22, 2026
1446 Decrease, Coupling of oxidative phosphorylation
3 Cellular Jun 29, 2017 Nov 7, 2025
2098 Increase, Abnormal Neural Remodeling
3 Tissue Jan 25, 2023 Jul 26, 2024 483: Deposition of Energy Leading to Learning and Memory Impairment
2090 Increase, Bone Remodeling
3 Tissue Jan 11, 2023 Aug 13, 2024 482: Deposition of energy leading to occurrence of bone loss
2118 Succinate dehydrogenase, inhibited
3 Molecular Apr 3, 2023 May 4, 2023
1869 Diminished protective oxidative stress response
3 Cellular Apr 20, 2021 Oct 30, 2023
1867 Bradykinin system, hyperactivated
3 Molecular Apr 20, 2021 Jan 24, 2022 392: Decreased fibrinolysis and activated bradykinin system leading to hyperinflammation
1901 Interferon-I antiviral response, antagonized by SARS-CoV-2
3 Cellular Jul 9, 2021 Dec 15, 2023
2078 Loss of drebrin
3 Cellular Dec 11, 2022 Apr 3, 2025
2089 Altered Bone Cell Homeostasis
2 Cellular Jan 11, 2023 Aug 23, 2024
2091 Occurrence, Bone Loss
2 Organ Jan 11, 2023 Aug 23, 2024 482: Deposition of energy leading to occurrence of bone loss
2147 Decreased, Viable Offspring
2 Individual Jun 2, 2023 Apr 10, 2024
2028 Decrease, GLI1/2 translocation to nucleus
2 Molecular Jul 15, 2022 Oct 28, 2022
2042 Increase, Orofacial clefting
2 Individual Jul 27, 2022 Apr 3, 2025
2041 Decrease, facial prominence outgrowth
2 Tissue Jul 27, 2022 Apr 3, 2025